Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Feb-24 4:15 PM View:  | Neumora Therapeutics, Inc. (NMRA) | 14-Feb-24 | Grant | 80,000 | -- | -- | 15% 524.79K to 604.79K | |
| 19-Sep-23 9:47 PM View: | Neumora Therapeutics, Inc. (NMRA) | 19-Sep-23 | Purchase | 15,000 | $12.62 | $189,370.00 | 3% 509.79K to 524.79K | |
| 11-May-23 9:06 PM View: | Acelyrin, Inc. (SLRN) | 09-May-23 | Purchase | 50,000 | $18.00 | $900,000.00 | 100% 0 to 50.0K | |
| 18-May-22 5:12 PM View: | Abbvie Inc. (ABBV) | 16-May-22 | Option Exercise | 83,960 | $54.86 | $4,606,050.00 | 85% 98.58K to 182.54K | |
| 18-May-22 5:12 PM View: | Abbvie Inc. (ABBV) | 16-May-22 | Option Sale | 83,960 | $155.00 | $13,013,800.00 | (46%) 182.54K to 98.58K | |
| 01-Mar-22 6:14 PM View: | Abbvie Inc. (ABBV) | 01-Mar-22 | Sale | 15,000 | $148.26 | $2,223,840.00 | (11%) 138.58K to 123.58K | |
| 02-Mar-22 5:03 PM View: | Abbvie Inc. (ABBV) | 01-Mar-22 | Private Sale | 25,000 | $147.29 | $3,682,190.00 | (20%) 123.58K to 98.58K | |
| 01-Mar-22 6:14 PM View: | Abbvie Inc. (ABBV) | 25-Feb-22 | Payment of Exercise | 30,156 | $149.54 | $4,509,530.00 | (18%) 168.74K to 138.58K | |
| 22-Feb-22 5:39 PM View: | Abbvie Inc. (ABBV) | 17-Feb-22 | Grant | 68,068 | -- | -- | 68% 100.67K to 168.74K | |
| 10-Sep-21 5:01 PM View: | Abbvie Inc. (ABBV) | 07-Sep-21 | Gift | 30,000 | -- | -- | 30% 100.5K to 130.5K | |
| 10-Sep-21 5:01 PM View: | Abbvie Inc. (ABBV) | 07-Sep-21 | Gift | 30,000 | -- | -- | (23%) 130.5K to 100.5K | |
| 02-Mar-21 8:34 PM View: | Abbvie Inc. (ABBV) | 28-Feb-21 | Payment of Exercise | 22,833 | $107.74 | $2,460,030.00 | (19%) 123.19K to 100.36K | (< 1%) |
| 22-Feb-21 6:25 PM View: | Abbvie Inc. (ABBV) | 18-Feb-21 | Grant | 51,538 | -- | -- | 72% 71.37K to 122.91K | |
| 24-Nov-20 5:34 PM View: | Abbvie Inc. (ABBV) | 20-Nov-20 | Market Sale | 40,000 | $99.38 | $3,975,050.00 | (24%) 164.48K to 124.48K | (3%) |
| 24-Apr-20 5:10 PM View: | Abbvie Inc. (ABBV) | 06-Apr-20 | Gift | 18,500 | -- | -- | 17% 111.27K to 129.77K | |
| 24-Apr-20 5:10 PM View: | Abbvie Inc. (ABBV) | 06-Apr-20 | Gift | 18,500 | -- | -- | (14%) 129.77K to 111.27K | |
| 03-Mar-20 4:53 PM View: | Abbvie Inc. (ABBV) | 28-Feb-20 | Payment of Exercise | 26,038 | $85.42 | $2,224,170.00 | (19%) 136.82K to 110.78K | (16%) |
| 24-Feb-20 6:02 PM View: | Abbvie Inc. (ABBV) | 20-Feb-20 | Grant | 58,781 | -- | -- | 75% 78.04K to 136.82K | |
| 14-Jan-20 4:19 PM View: | Aptinyx Inc. (APTX) | 10-Jan-20 | Market Purchase | 25,000 | $3.00 | $75,000.00 | 25% 100.0K to 125.0K | 21% |
| 07-Oct-19 4:36 PM View: | Aptinyx Inc. (APTX) | 04-Oct-19 | Gift | 100,000 | -- | -- | 100% 100.0K to 200.0K | |
| 07-Oct-19 4:36 PM View: | Aptinyx Inc. (APTX) | 04-Oct-19 | Gift | 100,000 | -- | -- | (50%) 200.0K to 100.0K | |
| 16-Aug-19 4:11 PM View: | Abbvie Inc. (ABBV) | 14-Aug-19 | Gift | 30,000 | -- | -- | 38% 78.04K to 108.04K | |
| 16-Aug-19 4:11 PM View: | Abbvie Inc. (ABBV) | 14-Aug-19 | Gift | 30,000 | -- | -- | (28%) 108.04K to 78.04K | |
| 31-Jul-19 4:46 PM View: | Abbvie Inc. (ABBV) | 29-Jul-19 | Market Purchase | 30,000 | $67.28 | $2,018,390.00 | 62% 48.04K to 78.04K | 43% |
| 09-May-19 10:01 AM View: | Aptinyx Inc. (APTX) | 08-May-19 | Market Purchase | 96,580 | $3.86 | $372,799.00 | 2824% 3.42K to 100.0K | (6%) |
| 09-May-19 10:01 AM View: | Aptinyx Inc. (APTX) | 07-May-19 | Market Purchase | 3,420 | $3.75 | $12,825.00 | 100% 0 to 3.42K | (3%) |
| 04-Mar-19 4:55 PM View: | Abbvie Inc. (ABBV) | 28-Feb-19 | Payment of Exercise | 22,956 | $79.41 | $1,822,940.00 | (32%) 70.75K to 47.8K | (21%) |
| 22-Feb-19 5:19 PM View: | Abbvie Inc. (ABBV) | 21-Feb-19 | Grant | 51,815 | -- | -- | 274% 18.94K to 70.75K | |
| 11-Dec-18 4:59 PM View: | Abbvie Inc. (ABBV) | 09-Dec-18 | Payment of Exercise | 13,446 | $86.96 | $1,169,260.00 | (42%) 32.16K to 18.71K | (12%) |
| 30-Nov-18 5:22 PM View: | Abbvie Inc. (ABBV) | 29-Nov-18 | Market Sale | 42,450 | $90.10 | $3,824,940.00 | (57%) 74.61K to 32.16K | (8%) |
| 02-Mar-18 5:29 PM View: | Abbvie Inc. (ABBV) | 28-Feb-18 | Payment of Exercise | 17,418 | $118.26 | $2,059,850.00 | (19%) 91.91K to 74.49K | 20% |
| 16-Feb-18 5:54 PM View: | Abbvie Inc. (ABBV) | 15-Feb-18 | Grant | 39,316 | -- | -- | 75% 52.53K to 91.85K | |
| 11-Dec-17 5:23 PM View: | Abbvie Inc. (ABBV) | 09-Dec-17 | Payment of Exercise | 14,235 | $95.95 | $1,365,850.00 | (21%) 66.61K to 52.37K | 3% |
| 31-Oct-17 5:04 PM View: | Abbvie Inc. (ABBV) | 30-Oct-17 | Market Sale | 18,300 | $90.55 | $1,657,040.00 | (22%) 84.87K to 66.57K | (3%) |
| 02-Aug-17 5:05 PM View: | Abbvie Inc. (ABBV) | 31-Jul-17 | Market Sale | 18,000 | $70.09 | $1,261,640.00 | (17%) 103.11K to 85.11K | (32%) |
| 02-Aug-17 5:06 PM View: | Abbvie Inc. (ABBV) | 31-Jul-17 | Market Sale | 300 | $70.42 | $21,127.00 | (< 1%) 168.74K to 168.44K | (32%) |
| 02-Mar-17 6:12 PM View: | Abbvie Inc. (ABBV) | 28-Feb-17 | Payment of Exercise | 20,673 | $62.22 | $1,286,270.00 | (17%) 123.51K to 102.84K | (46%) |
| 21-Feb-17 5:51 PM View: | Abbvie Inc. (ABBV) | 16-Feb-17 | Grant | 45,231 | -- | -- | 58% 78.2K to 123.43K | |
| 09-Dec-16 5:08 PM View: | Abbvie Inc. (ABBV) | 09-Dec-16 | Payment of Exercise | 13,871 | $60.90 | $844,744.00 | (15%) 91.05K to 77.18K | (48%) |
| 11-Dec-15 5:22 PM View: | Abbvie Inc. (ABBV) | 09-Dec-15 | Grant | 91,050 | -- | -- | 100% 0 to 91.05K |